Does “5-2-1” identify patients with suspected Advanced Parkinson’s Disease? Evidence of clinical accuracy from G7 countries
Objective: Evaluate the psychometric properties of (i) the “5-2-1” criteria and (ii) consensus-driven clinical indicators of suspected advanced Parkinson’s disease (APD). Background: Recent consensus panel…Prevalence of Spread of Dystonia and its effect on health-related quality of life in an Irish population with adult-onset isolated cervical dystonia.
Objective: We aim to characterize clinical and demographic features and assess prevalence of spread of dystonia in relation to health-related quality of life in CD…Non-motor Symptoms after Treatment with Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson’s Disease: Analysis of the COSMOS Observational Study
Objective: Examine non-motor symptoms in patients with advanced Parkinson’s disease (APD) in a real-world clinical setting following ≥12 months of treatment with levodopa-carbidopa intestinal gel…The Presence of Efferent Brain-Gut Neuropathy Correlates with Severe Constipation in Parkinson’s disease
Objective: We aim to correlate brain-gut neuropathy amongst cortico- and lumbosacro-anorecal efferent pathways in PD subjects with severe constipation measured by prospective stool diary. Background:…What Matters Most to Individuals with Parkinson’s Disease: Results from Qualitative Interviews
Objective: To use interviews from individuals with Parkinson's disease (PD) to better understand the symptomology of the disease. Background: It is important to understand the…Application of a Simple Parkinson’s Disease Risk Score in a Longitudinal Population Based Cohort
Objective: To apply the PREDICT-PD algorithm of risk indicators for Parkinson’s disease (PD), in a prospective community-based study (the Bruneck Study), representative of the general…Long-term quality of life after subthalamic deep brain stimulation depends on non-motor symptoms in Parkinson’s disease
Objective: To predict 36-month follow-up quality of life (QoL) outcome after bilateral subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson’s disease (PD). Background: STN-DBS improves…Gender-related differences in nonmotor symptoms in the context of subthalamic stimulation in Parkinson’s disease
Objective: To investigate gender differences in quality of life, motor, and nonmotor symptoms (NMS) in patients with Parkinson’s disease (PD) undergoing subthalamic nucleus deep brain…Quality of Life in Mexican Patients with Essential Tremor
Objective: Identify among patients attending the Movement Disorders Unit at the National Institute of Neurology and Neurosurgery, Mexico, how much quality of life is reduced…Performance at the Category-Exemplars language test (CATEX) in Parkinson’s disease and Huntington’s disease Italian population
Objective: This study aims to explore CATEX sensitivity to detect early cognitive deficits in Huntington’s disease (HD) and Parkinson’s disease (PD) Italian population. Background: PD…
- « Previous Page
- 1
- …
- 25
- 26
- 27
- 28
- 29
- …
- 55
- Next Page »